Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible acinetobacter baumannii strains;Sefoperazon-sulbaktam, imipenem ve sefepimin antibiyoterapi etkinliklerinin çoǧul dirençli ve duyarli acinetobacter baumannii ile oluşturulan deneysel ikili apse modelinde karsşilaş tirilmasi

Mikrobiyoloji Bulteni

Volumn 45, Issue 3, 2011, Pages 422-429

  Yildirim, M Ishak ^a   Tuǧrul, H Murat ^b  

^a Silivri State Hospital   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

Author keywords

Abscess; Acinetobacter baumannii; Cefaperazone sulbactam; Cefepime; Experimental model; Imipenem

Indexed keywords

ANTIINFECTIVE AGENT; CEFEPIME; CEFOPERAZONE; CEPHALOSPORIN DERIVATIVE; IMIPENEM; SULBACTAM;

ABSCESS; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; BLOOD; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECT; FEMALE; MICROBIOLOGY; MULTIDRUG RESISTANCE; RANDOMIZATION; RAT; SOFT TISSUE INFECTION; THIGH; WISTAR RAT;

ABSCESS; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; CEFOPERAZONE; CEPHALOSPORINS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; IMIPENEM; RANDOM ALLOCATION; RATS; RATS, WISTAR; SERUM BACTERICIDAL TEST; SOFT TISSUE INFECTIONS; SULBACTAM; THIGH;

EID: 80052485601     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Berezin BE, Towner KJ. Acinetobacter spp. as nosocomial pathogens. Microbiological, clinical and epidemiological features. Clin Microbiol Rev 1996; 9(2): 148-65. (Pubitemid 26123943)
2. Taşova Y, Akgün Y, Saltoǧlu N, Yilmaz G, Kara O, Dündar IH. Nozokomiyal Acinetobacter infeksiyonlari. Flora 1999; 4(3): 170-6.
3. Towner KJ. Acinetobacter. an old friend, but a new enemy. J Hosp Infect 2009; 73(4): 355-63.
4. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000; 31(1): 101-6. (Pubitemid 32268946)
5. Tatman-Otkun M, Gürcan Ş, Özer B, Türe M. Nozokomiyal Acinetobacter baumannii kökenlerinde 1994'den 2000'e yillik antibiyotik direnç deǧişimi. ANKEM 2003; 17(1): 1-6.
6. Kolayli F, Karadenizli A, Mutlu B, et al. Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against Acinetobacter baumannii strains in terms of bactericidal efficacy and resistance selection. Ann Clin Microbiol Antimicrob 2004; 3(1): 1-5.
7. Karadenizli A, Mutlu B, Okay E, Kolayli F, vahaboǧlu H. Piperacillin with and without tazobactam against extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa in a rat thigh abscess model. Chemother 2001; 47(4): 292-6. (Pubitemid 32588789)
8. Yüce A. Hastane infeksiyonlarinin önemi, s: 3-6. Yüce A, Çakir N (ed), Hastane Infeksiyonlan. 2003, 1. baski. Güven Kitabevi, Izmir.
9. Maragakis LL, Perl TM. Acinetobacter baumannil: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008; 46(8): 1254-63. (Pubitemid 351589912)
10. Vahaboǧlu H, Saribaş S, Akbal H, Ozturk R, Yucel A. Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type β-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp. J Antimicrob Chemother 1998; 42(2): 269-70. (Pubitemid 28393602)